Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 1,589 | 585 | 623 | 578 | 737 |
| Gross Profit | 1,589 | 585 | 623 | 578 | 737 |
| Operating Expenses | 4,450 | 4,980 | 6,158 | 5,329 | 4,918 |
| Operating Income | -2,861 | -4,395 | -5,535 | -4,751 | -4,181 |
| Other Income | 304 | 0 | 0 | 13 | 25 |
| Pre-tax Income | -2,557 | -4,395 | -5,535 | -4,738 | -4,156 |
| Net Income Continuous | -2,557 | -4,395 | -5,535 | -4,738 | -4,156 |
| Net Income | $-2,557 | $-4,395 | $-5,535 | $-4,738 | $-4,156 |
| EPS Basic Total Ops | 0.40 | -4.40 | -6.80 | -6.20 | 20.20 |
| EPS Basic Continuous Ops | 0.39 | -4.37 | -6.82 | -6.17 | 20.20 |
| EPS Diluted Total Ops | 0.40 | -4.40 | -6.80 | -6.20 | 20.20 |
| EPS Diluted Continuous Ops | 0.39 | -4.37 | -6.82 | -6.17 | 20.20 |
| EBITDA(a) | $-2,861 | $-4,395 | $-5,535 | $-4,751 | $-4,181 |